# To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension

> **NCT03975374** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sutphin Drugs** · enrollment: 5000 (estimated)

## Conditions studied

- Blepharo Conjunctivitis

## Interventions

- **DRUG:** Tobramycin/dexamethasone opthalmic solution
- **DRUG:** Tobradex Opthalmic Solution

## Key facts

- **NCT ID:** NCT03975374
- **Lead sponsor:** Sutphin Drugs
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-15
- **Primary completion:** 2019-07-01
- **Final completion:** 2020-06-30
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2019-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03975374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03975374, "To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03975374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*